What have we learnt from Vioxx?

Krumholz. (2004). What have we learnt from Vioxx?. BMJ.

Type

Journal article

Intellectual base

Primary research

Year

2004

DOI

10.1136/bmj.39024.487720.68

Link

https://doi.org/10.1136/bmj.39024.487720.68

Cited by

1 citation across 1 artifact.

Domain-specific

• Adverse Drug Event
  • Approved in 1999 as a COX-2-selective anti-inflammatory that spared the stomach, it was taken by millions

Verification

This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.

Registry ID ref:5fef44f95020 · see in the full table